...
首页> 外文期刊>World Journal of Gastroenterology >Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.
【24h】

Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma.

机译:胰岛素样生长因子Ⅱ信使RNA在肝细胞癌患者肝癌组织和外周血中的表达和改变。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To investigate the clinical values of serum free insulin-like growth factor II (IGF-II) levels and IGF-II mRNA in hepatocellular carcinoma (HCC) tissues and peripheral blood for diagnosis of HCC and monitoring of extrahepatic metastasis. METHODS: Total RNAs were extracted from HCC tissues or peripheral blood mononuclear cells from patients with HCC, liver diseases devoid of cancer, non-hepatic tumors, and healthy controls, respectively. IGF-II cDNAs were synthesized through random primers and reverse-transcriptase, amplified by polymerase chain reaction (PCR), and confirmed by DNA sequencing analysis. Serum free IGF-II levels in patients with different liver diseases were analyzed by an enzyme-linked immunosorbent assay. RESULTS: The amplified fragments of IGF-II mRNA by RT-PCR were identical to originally designed ones with a size of 170 bp and confirmed by sequencing analysis. The dilution experiments revealed that the lowest sensitivity of our system was 2 ng/L of total RNA. The positive frequencies of IGF-II mRNA were 100% in HCC tissues, 53.3% in para-cancerous tissues, and 0% in non-cancerous tissues, respectively. The serum free IGF-II levels were significantly higher in HCC than those in chronic hepatitis or liver cirrhosis. The positive frequency of circulating IGF-II mRNA was 34.2% in HCC, no amplified fragment was found in other liver diseases, extrahepatic tumors, and normal controls, respectively. The circulating IGF-II mRNA correlated with the stage of HCC, and its positive rate was 100% in HCC with extrahepatic metastasis and 35.5% in HCC with AFP-negative. No significant correlation was found between tumor sizes and circulating IGF-II mRNA fragment. CONCLUSION: The abnormal expressions of free IGF-II and IGF-II mRNA are useful tumor markers for HCC diagnosis, differentiation of extrahepatic metastasis and monitoring postoperative recurrence.
机译:目的:探讨肝细胞癌(HCC)组织和外周血中游离胰岛素样生长因子II(IGF-II)和IGF-II mRNA的水平对肝癌的诊断及肝外转移的临床价值。方法:从肝癌,无癌肝病,非肝肿瘤和健康对照组的肝癌组织或外周血单个核细胞中提取总RNA。通过随机引物和逆转录酶合成IGF-II cDNA,通过聚合酶链反应(PCR)进行扩增,并通过DNA测序分析进行确认。通过酶联免疫吸附试验分析了不同肝脏疾病患者的无血清IGF-II水平。结果:通过RT-PCR扩增的IGF-II mRNA片段与最初设计的片段相同,大小为170 bp,经测序分析证实。稀释实验表明,我们系统的最低灵敏度是总RNA的2 ng / L。 IGF-II mRNA的阳性频率在肝癌组织中为100%,在癌旁组织中为53.3%,在非癌组织中为0%。 HCC患者的血清游离IGF-II水平明显高于慢性肝炎或肝硬化患者。在肝癌中循环IGF-II mRNA的阳性频率为34.2%,在其他肝病,肝外肿瘤和正常对照组中未发现扩增片段。循环的IGF-II mRNA与肝癌的分期相关,在肝外转移的肝癌中其阳性率为100%,在AFP阴性的肝癌中其阳性率为35.5%。在肿瘤大小和循环的IGF-II mRNA片段之间未发现显着相关性。结论:游离IGF-II和IGF-II mRNA的异常表达为肝癌的诊断,肝外转移的分化和术后复发的监测提供了有用的肿瘤标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号